ArticleBMC cancer2026

High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study.

Çiğdem Öztürk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.